hotspot -WSS

hotspot

author：fashion 2025-09-28 22:53:11 - browse：12

Photo of an arrangement of aspirin pills — Patrick Sison/AP

Low-dose aspirin led to a reduction in liver fat among patients with metabolic-associated liver disease, a small study out of Boston found.

The clinical trial, led by Tracey Simon of Massachusetts General Hospital and Harvard Medical School, compared two groups of patients with metabolic dysfunction-associated steatotic liver disease, or MASLD. One group was given baby aspirin daily for six months, while the other received a placebo pill. At the end of the study period, the aspirin group had reduced hepatic fat content while the placebo group had higher fat buildup.

MASLD (formerly known as non-alcoholic fatty liver disease) is a growing health threat, with 1 in 3 Americans having a troublesome amount of fat in their liver. The lipid buildup feeds into a toxic cycle of inflammation, tissue damage and, ultimately, irreversible scarring.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Medical records are filled with copy
Next article： Venture capitalist Bob Kocher on the state of digital health

leisure time

WSS

Readers respond to H5N1 and livestock movements, and more

Military medical care influenced by rank and race, new study finds

Big Tobacco's 'harm reduction': Is it for real, or a sham?

NVIDIA and Google execs on the future of AI and drug discovery

Akero's treatment for NASH falls short in cirrhosis study

Wearables generate powerful data but its not useful to doctors, yet

entertainment

hotspot

entertainment

How to save PrEP access — and even expand it

Cytokinetics CEO stresses company can launch heart drug on its own

Psychedelics group wrestles with new pharma identity

Takeaways from AdvaMed, the largest medical devices conference

Malaria cases in Florida and Texas: Here’s what you need to know

With measles on the rise, a personal story of a devastating disease

Jerome Adams on the need for new antivirals for Covid

Anxious about a speech? A startup wants you to pop a minty cardiac drug

Drug repurposing or repositioning? The language matters

Military medical care influenced by rank and race, new study finds

Wikipedia

Wellcome Trust’s new CEO hopes Big Tech gets more involved in public health

Life sciences deals on track to hit lowest point since 2017

Nick Jonas talks about managing diabetes along with his career

Venture capitalist Bob Kocher on the state of digital health

Medicare to cover more brain scans related to Alzheimer’s drugs

The Readout: Lisata, Eisai x Biogen, and the Met Gala (!)

leisure time

leisure time

leisure time

focus